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Abstract A non-hypoxic, reactive oxygen species (ROS)-
sensitive pathway mediating tumor necrosis factor-K (TNF-K)-
dependent regulation of hypoxia-inducible factor-1K (HIF-K)
was investigated in vitro. TNF-K mediated the translocation of
HIF-1K, associated with up-regulating its activity under
normoxia. Analysis of the mode of action of TNF-K revealed
the accumulation of hydrogen peroxide (H2O2), superoxide
anion (O32 ) and hydroxyl radical (
OH). Antioxidants pur-
ported as prototypical scavengers of H2O2 and OH, attenuated
TNF-K-induced HIF-1K activation, and blockading NADPH-
oxidase by scavenging O32 reduced the activity of HIF-1K.
Inhibition of the mitochondrion complex I abrogated TNF-K-
dependent activation of HIF-1K. Interrupting the respiratory
chain reversed the excitatory effect of TNF-K on HIF-1K. These
results indicate a non-hypoxic pathway mediating cytokine-
dependent regulation of HIF-1K in a ROS-sensitive
mechanism. ß 2001 Federation of European Biochemical So-
cieties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The hypoxia-inducible factor-1K (HIF-1K), identi¢ed as a
DNA-binding activity expressed under hypoxic conditions,
has its stability and activity increased exponentially on low-
ering pO2 over physiologically relevant ranges [1]. The ubiq-
uitous activation of HIF-1K is thus consistent with the signi¢-
cant role that this transcription factor plays in coordinating
adaptive responses to hypoxia.
HIF-1 is a heterodimeric transcription factor consisting of
K and L subunits. The aryl hydrocarbon receptor nuclear
translocator (HIF-1L) can dimerize with the aryl hydrocarbon
receptor as well as with HIF-1K [1]. Whereas HIF-1L is con-
stitutively expressed under normoxic conditions, HIF-1K is
rapidly degraded by the ubiquitin-proteasome system [2].
However, under hypoxic conditions, HIF-1K is stabilized
and accumulated, allowing the heterodimer to translocate
and bind speci¢c promoter moieties of genes encoding eryth-
ropoietin (EPO), vascular endothelial growth factor (VEGF),
glycolytic transporters [3^5] and in£ammatory mediators [6^
8]. Therefore, HIF-1K may play an important role not only in
regulating the transcription of pO2-controlled genes and en-
ergy homeostasis, but also in£uence an immune response.
However, the mechanism of pro-in£ammatory cytokine-de-
pendent regulation of the translocation/activation of HIF-1K
is currently unknown.
Tumor necrosis factor (TNF)-K is a pleiotropic cytokine
with a plethora of multiple actions on cellular metabolism.
TNF-K has been implicated in the pathogenesis of respiratory
distress syndrome and pulmonary edema [9], in regulating ap-
optosis signaling and pathways [10,11] and in governing gene
expression [11,12]. In the lung, TNF-K is produced primarily
by activated pulmonary macrophages, however, evidence sug-
gested that it is produced in ¢broblasts and epithelial cells
[13^16]. Furthermore, the alveolar epithelium has been impli-
cated in regulating the immunological functions of the lung by
controlling pro-in£ammatory gene expression [17,18]. In the
present investigation, we studied the role that TNF-K plays in
regulating HIF-1K translocation/activation and subsequently
explored the underlying molecular pathway implicated.
2. Materials and methods
2.1. Chemicals and reagents
Unless otherwise indicated, chemicals of the highest analytical
grade were purchased from Sigma-Aldrich Co. Experimental proce-
dures were approved under the Animals Act, 1986 (UK).
2.2. Primary cell cultures of alveolar epithelia
Fetal alveolar type II epithelial cells were isolated from the lungs of
fetuses of pregnant rats, essentially as reported elsewhere [19,20]. The
adenylate energy charge, an index of cell viability and competence,
remained v0.7 and transepithelial monolayer resistance (Rt) was
monitored constantly at v250^350 6 cm2 [19].
2.3. Administration of recombinant murine (rm)TNF-K and analysis of
HIF-1K translocation/activation
Epithelial cells were exposed to rmTNF-K (10 ng/ml) for indicated
time periods. Nuclear extracts were prepared and Western/DNA-bind-
ing activity were subsequently performed, essentially as described else-
where [19,20]. Nuclear proteins (20^25 Wg) were resolved over SDS^
PAGE (7.5%) gels at room temperature and mouse monoclonal IgG1
anti-HIF-1K (Santa Cruz Biotechnology, UK) antibody was employed
for primary detection, followed by secondary detection in the presence
of streptavidin^horseradish peroxidase conjugate and then visualized
by chemiluminescence [19,20]. In addition, nuclear extracts were ana-
lyzed for HIF-1K DNA-binding activity by electrophoretic mobility
shift assay (EMSA), as detailed previously [19,20].
2.4. Assessment of intracellular reactive oxygen species (ROS)
accumulation with rmTNF-K
For the determination of H2O2, cell supernatants were collected
and centrifuged at 2000Ug for 5 min at 4‡C, and then treated with
1 M NaOH. The change in absorbancy at 600 nm was monitored
against phenol red solution (PRS) containing (in mM): 140 NaCl,
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10 K3PO4, 5.5 glucose, 0.28 phenol red, and 20 U/ml horseradish
peroxidase [15,16,21,22]. Standard curves using PRS and H2O2 were
prepared (0^100 WM), and results extrapolated from the linear regres-
sion were converted to nmol/mg protein. For the quanti¢cation of
O32 , supernatant was discarded after 24 h of culture, and cells were
then reincubated with rmTNF-K (37‡C) in the presence of 80 WM
ferricytochrome c (fc) suspended in Hank’s bu¡ered salt solution.
The amount of O32 released was determined by measuring the absor-
bancy at 550 nm against blanks containing fc and superoxide dismu-
tase (300 U/ml) [15,16,21,22]. For the determination of OH, cells
were cultured at 105/well in £at-bottomed microtiter plates, then
washed with sterile saline, and culturing was continued in Krebs^
Ringer solution containing 50 WM dihydrorhodamine and rmTNF-
K. Fluorescence was measured at excitation/emission wavelengths of
485/535 nm [15,16].
2.5. Pre-treatment with selective antioxidants prior to exposure to
exogenous rmTNF-K
In order to investigate the possibility of ROS as signaling messen-
gers in rmTNF-K-mediated regulation of HIF-1K, selective antioxi-
dants were employed. This choice was based on the antioxidant po-
tency and speci¢city: dimethyl sulfoxide (DMSO) is a scavenger of
OH [23,24]; 1,3-dimethyl-2-thiourea (DMTU) scavenges H2O2 and
OH [23^25]; and 4P-hydroxy-3P-methoxy-acetophenone (HMAP) is a
NADPH-oxidase inhibitor which neutralizes endogenous O32 [26].
Cells were pre-treated for 2 h with DMSO, DMTU or HMAP, then
exposed to rmTNF-K (10 ng/ml) for 30 min. Nuclear extracts were
prepared and DNA-binding activity of HIF-1K was subsequently per-
formed. Separately, to determine the level of participation of mito-
chondrial ROS, cells were pre-treated with diphenylene iodonium
(DPI), an inhibitor of the mitochondrial complex I [27], or KCN,
an inhibitor of the respiratory chain, followed by exposure to
rmTNF-K and assessment of the DNA-binding activity. In indepen-
dent experiments, to give a direct evidence of a ROS-generating system
through activation by rmTNF-K, cells were pre-treated with either
HMAP or DPI as above, then exposed to rmTNF-K (10 ng/ml) for
30 min, followed by assessment of intracellular ROS accumulation.
2.6. Statistical analysis and data handling
Data are the means and the error bars the S.E.M. Statistical anal-
ysis of the di¡erence in mean separation was performed by one-way
analysis of variance, followed by post-hoc Tukey’s test, and the a
priori level of signi¢cance at 95% con¢dence level was considered at
P90.05.
3. Results
3.1. The role of rmTNF-K in regulating the stability and
nuclear translocation of HIF-1K
Fig. 1 displays the e¡ect of rmTNF-K on the nuclear local-
ization of the HIF-1K subunit under normoxic conditions.
Fig. 1. TNF-K-mediated regulation of HIF-1K stabilization/translo-
cation. TNF-K (10 ng/ml) induced, in a time-dependent manner, sta-
bilization and nuclear accumulation of HIF-1K under normoxia.
HIF-1K protein was detected at 15 min, maximized at 0.5^4 h, and
still persistently abundant until 24 h, thereafter declining. L-Actin
was used as an internal reference for semi-quantitative loading per
lane. n = 3, which represents the number of independent experi-
ments.
Fig. 2. The e¡ect of TNF-K on HIF-1K activation. A: TNF-K increased the DNA-binding activity of HIF-1K in a time-dependent manner.
HIF-1K activity was detectable at 15 min, maximized at 0.5^1 h, and continued to be active until 24 h, thereafter declining. The faster migrat-
ing probe (FP) indicates the free, unbound probe, and the upper-shifted band is that of the HIF-1K/DNA complex. B: Histogram analysis of
the gel-shifted band as determined by phosphorimaging. *P6 0.05, **P6 0.01, ***P6 0.001, as compared with control in the absence of
rmTNF-K. n = 3, which represents the number of independent experiments.
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HIF-1K accumulation increased signi¢cantly as early as 15
min post-addition of rmTNF-K and continued to increase ex-
ponentially (maximizing at 0.5^4 h) until 24 h, thereafter de-
clining (Fig. 1). The housekeeping protein, L-actin, was used
as an internal reference for semi-quantitative loading per lane
(Fig. 1).
3.2. The e¡ect of rmTNF-K on the nuclear activation of
HIF-1K
In association with its ability to up-regulate HIF-1K nuclear
translocation, rmTNF-K induced the DNA-binding activity of
this transcription factor (Fig. 2A). EMSA analysis detected
HIF-1K activity as early as 15 min after addition of
rmTNF-K, became maximally active at around 0.5^1 h, per-
sistently active until 24 h, thereafter declining (Fig. 2A). His-
togram analysis of the gel-shifted bands as performed by
phosphorimaging is displayed in Fig. 2B. In order to verify
Fig. 3. Speci¢city of HIF-1K gel-shifted band in response to
rmTNF-K. No detectable activity was recorded for HIF-1K in con-
trol nuclear samples containing no rmTNF-K. Addition of rmTNF-
K (10 ng/ml) induced the activity of HIF-1K. Incubation with the
mutant oligonucleotide (HIF-1K, M-18) abolished the shifted band.
Pre-incubation with K-HIF-1K antibody caused the appearance of a
further retarded band, with time e¡ect evident ranging from 2^24 h.
The cold competitor (COMP) abolished the speci¢c band of HIF-1K
obtained due to rmTNF-K. The faster migrating probe (FP) indi-
cates the free, unbound probe, the upper-shifted band is that of the
HIF-1K/DNA complex, and SS indicates the super shift. n = 3,
which represents the number of independent experiments.
C
 
 
 
 
 
 
Fig. 4. Analysis of ROS accumulation in response to rmTNF-K and the role of selective antioxidants. A: H2O2 began to increase at 15 min
and continued to be signi¢cantly higher than control until 24 h, thereafter declining. B: O32 appeared at 15 min and continued to be higher
than control until 24 h, thereafter declining. C: The concentration of OH (£uorescence) began to increase at 15 min and continued to be sig-
ni¢cantly higher than control until 24 h, thereafter declining. D: HMAP and DPI pre-treatments reduced accumulation of H2O2 in response to
rmTNF-K. E: HMAP and DPI reduced accumulation of O32 in response to rmTNF-K in a dose-dependent manner. F: HMAP and DPI
mildly reduced accumulation of OH in response to rmTNF-K. PP6 0.05, as compared with control; *P6 0.05, **P6 0.01, ***P6 0.001, as
compared with control in the absence or presence of rmTNF-K. n = 4, which represents the number of independent experiments run in dupli-
cate.
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the speci¢city of the shifted bands corresponding to HIF-1K,
supershift analysis was performed. As shown in Fig. 3,
rmTNF-K had no e¡ect on the binding activity of HIF-1K
(control) ; in contrast, rmTNF-K induced the activity of
HIF-1K. Pre-incubating nuclear extracts with a speci¢c mono-
clonal antibody raised against the K subunit induced a super-
shift retarded band relative to that induced by rmTNF-K
alone (Fig. 3). Nuclei incubated with K-HIF-1K for 2 h
showed a faint supershifted band, whereas pre-incubation
for 8 or 24 h exhibited a clearer supershifted band (Fig. 3).
To further delineate the speci¢city of HIF-1K bands, extracts
were incubated in the presence of the mutant oligonucleotide
versus the wild-type, where M-18 is shown to suppress the
e¡ect of rmTNF-K. Addition of cold competitor abrogated
rmTNF-K-induced HIF-1K DNA-binding activity (Fig. 3).
3.3. The e¡ect of rmTNF-K on intracellular accumulation of
ROS
The underlying mechanism of the mode of action of
rmTNF-K was investigated. TNF-K induced in a time-depen-
dent manner the accumulation of H2O2 (Fig. 4A), O32 (Fig.
4B) and OH (Fig. 4C). In order to assess the likely source of
ROS in response to rmTNF-K, cells were pre-treated with
HMAP or DPI prior to exposure to rmTNF-K for 30 min.
As shown in Fig. 4, HMAP and DPI reduced H2O2 accumu-
lation (Fig. 4D), but to a lesser extent than O32 (Fig. 4E). The
e¡ect of HMAP on OH was milder than that of DPI (Fig.
4F). These results indicated that both the membrane-bound
NADPH oxidase and the mitochondrial complex are di¡er-
entially involved as potential resources for ROS in response to
rmTNF-K. Correlation studies were performed to determine
the degree of statistical con¢dence between intracellular accu-
mulation of ROS in response to rmTNF-K and the activity of
HIF-1K. Fig. 5 shows that there is a positive correlation be-
tween H2O2 (Fig. 5A), O3:2 (Fig. 5B) and (
OH) accumulation
and HIF-1K activation (Fig. 5C).
3.4. The e¡ect of selective antioxidants on rmTNF-K-induced
HIF-1K activation
To con¢rm statistical correlation observed, we investigated
the role of selective antioxidants and determined the level of
involvement of the mitochondrial complex. The e¡ect of
DMSO on rmTNF-K-dependent activation of HIF-1K is
shown in Fig. 6A (IC50 = 1.12 þ 0.08%), that for DMTU in
Fig. 6B (IC50 = 0.67 þ 0.05 mM), that for HMAP in Fig. 6C
 
Fig. 5. Subset correlation analysis of ROS on the activation of
HIF-1K. A: Correlation with H2O2. B: Correlation with O32 . C:
Correlation with OH. The regression wizard lines represent the de-
gree of con¢dence at 95% limit. n = 3, which represents the number
of independent experiments.
Fig. 6. Analysis of the e¡ect of antioxidants and mitochondrial res-
piration inhibitors on rmTNF-K-mediated HIF-1K activation. A:
The inhibitory e¡ect of DMSO (e¡ective a doses v0.2%). B: The
inhibitory e¡ect of DMTU (e¡ective a doses v0.1 mM). C: The in-
hibitory e¡ect of HMAP (e¡ective a doses v0.1 mM). D: The in-
hibitory e¡ect of DPI (e¡ective a doses v0.1 WM). E: The inhibi-
tory e¡ect of KCN (e¡ective a doses v0.1 mM). n = 3, which
represents the number of independent experiments. FP: Faster mi-
grating probe.
FEBS 25235 7-9-01
J.J. Haddad, S.C. Land/FEBS Letters 505 (2001) 269^274272
(IC50 = 0.62 þ 0.07 mM), that for DPI in Fig. 6D
(IC50 = 0.64 þ 0.10 WM) and that for KCN in Fig. 6E
(IC50 = 0.52 þ 0.10 mM).
4. Discussion
The present investigation revealed a novel role for ROS
signalling in mediating the e¡ect of TNF-K on HIF-1K stabi-
lization, translocation and activation. Despite that HIF-1K
was recognized as a transcriptional activity prevailing under
hypoxic conditions that transiently gets degraded with ascend-
ing vpO2 [1,31], ROS mediating the regulation of HIF-1K
stabilization, translocation and activation have recently
emerged as potential regulatory mechanisms [27^31]. Consis-
tent with this notion, we reported for the ¢rst time a non-
hypoxic pathway mediating the e¡ect of TNF-K regulating the
translocation/activation of HIF-1K in an ROS-dependent
mechanism. Our results have clearly negated the hypothesis
that hypoxia is the only major player in HIF-1K regulation
and that this pathway mediated by TNF-K, for the moment
speci¢c to alveolar epithelial cells, should confer a major role
in controlling the mechanism mediating HIF-1K regulation
under normoxia.
The concept has been put forward that ROS events are
master regulators of HIF-1K, however, the signalling pathway
implicated awaits clari¢cation. On the mechanism of the non-
hypoxic regulation of HIF-1K, Chandel et al. [27,28] reported
a role for mitochondrial ROS generated at complex III and
that depletion of mitochondrial genome reversed ROS-medi-
ated induction of HIF-1K. Furthermore, it has been reported
that HIF-1K-dependent transcriptional activity mediating
VEGF induction has de¢ned an hypoxia-independent mecha-
nism regulating vascular remodeling [29]. Further a¢eld, re-
cent evidence suggested that reactive nitrogen species regulate
the stability/activation of HIF-1K. For instance, it was shown
that expression of nitric oxide (NO) synthase induced HIF-1K
accumulation, which underscored the role of NO as an intra-
cellular activator of this transcription factor [30,31].
The molecular pathways governed by cytokines mediating
HIF-1K regulation are not understood. Recently, Hellwig-
Bu«rgel et al. [7] reported a role for interleukin (IL)-1L and
TNF-K as mediators in stimulating the DNA-binding activity
of HIF-1K, concluding that it is likely to be involved in mod-
ulating gene expression during in£ammation. The augmented
activity of HIF-1K due to IL-1L was attributed to increased
HIF-1K protein abundance, whereas the e¡ect of TNF-K was
proposed to be due to concomitant activation of certain pro-
teins forming part of the activated complex [7,32]. Moreover,
cAMP responsive element-binding protein has been implicated
in augmenting HIF-1K activity within its site in the EPO gene
enhancer [33]. Despite the observation that there was failure
at demonstrating any e¡ect of in£ammatory cytokines on
cAMP levels and PKA activity, it was noted that the addition
of cAMP analogues prevented the suppression of EPO medi-
ated by cytokines [34].
Amongst the cytokines most known for their in£ammatory
actions, perhaps TNF-K is the one exhaustively investigated.
TNF-K is a potent in£ammatory cytokine, which exerts its
pleiotropic activities through ligand-induced cross-linking of
speci¢c receptors, virtually present in almost all cell types [35].
TNF-K released in the in£ammatory milieu transiently acti-
vates neutrophils and macrophages, thereby causing them to
release O32 as a consequence of the activation of NADPH
oxidase [36]. This oxidative burst features a rapid release of
ROS and is a crucial part of the defense mechanism against
invading microbial pathogens and tumor cell metastasis.
Although TNF-K is primarily produced by macrophages,
growing evidence suggests that other cell types release TNF-
K and other in£ammatory mediators, thereby amplifying and
boosting the in£ammatory reaction [15,16,18,37]. In this re-
spect, it has been reported that TNF-K up-regulates intracel-
lular accumulation of ROS [14]. More recently, Corda et al.
[38] speci¢cally de¢ned a role of the mitochondrion in TNF-
K-mediated ROS generation. Our results, indicating a poten-
tial role for TNF-K in accumulating intracellular ROS, jibe
with the notion that this cytokine mediates its e¡ect through
an ROS-dependent mechanism. On the likely source of ROS,
we report the convergence of two possible pathways: (i) the
membrane-bound NADPH oxidase and (ii) the respiratory
chain of the mitochondrial complexes. Both resources are
likely to be implicated in mediating the e¡ect of TNF-K on
HIF-1K induction. The latter mechanism is rather directly
involved since blockading the mitochondrial complex I and
respiratory chain abrogated TNF-K-dependent HIF-1K acti-
vation. Furthermore, we provided evidence that di¡erent ROS
species are implicated in mediating the e¡ect of TNF-K on
HIF-1K translocation/activation. The observation that a
non-hypoxic pathway mediated by ROS generated within
the mitochondrion complex regulates cytokine-dependent
HIF-1K induction is rather unequivocal since DPI, an inhib-
itor of complex I which blockades the conversion of ubiqui-
noneCubiquinol [27,28,31], almost totally abrogated TNF-K-
induced HIF-1K activation, suggesting a vital role for mito-
chondrial ROS.
The present investigation has thrown a shadow of light on
the mechanism of action of TNF-K mediating its inductive
e¡ect on HIF-1K. The results could be highlighted as follows:
(i) TNF-K allowed the stabilization and nuclear translocation
of HIF-1K under normoxic conditions; (ii) this e¡ect was
associated with inducing HIF-1K DNA-binding activity; (iii)
TNF-K augmented intracellular accumulation of ROS; (iv)
selective antioxidants attenuated TNF-K-mediated activation
of HIF-1K ; and (v) blockading the mitochondrion complex I
and its respiratory chain abrogated TNF-K-dependent HIF-
1K activation. It is concluded that cytokine-mediated regula-
tion of HIF-1K stabilization, translocation and activation re-
quires a non-hypoxic, ROS-sensitive mechanism.
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